title: Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.
abstract: The treatment of soft tissue tumors needs the coordinated adoption of surgery with radiation therapy and eventually, chemotherapy. The radiation therapy (delivered with a linear accelerator) can be preoperative, intraoperative, or postoperative. In selected patients adjuvant brachytherapy can be adopted. The goal of these associations is to achieve tumor control while maximally preserving the normal tissues from side effects. Unfortunately, the occurrence of local and distant complications is still elevated. Electrochemotherapy is a novel technique that combines the administration of anticancer agents to the application of permeabilizing pulses in order to increase the uptake of antitumor molecules. While its use in humans is still confined to the treatment of cutaneous neoplasms or the palliation of skin tumor metastases, in veterinary oncology this approach is rapidly becoming a primary treatment. This review summarizes the recent progresses in preclinical oncology and their possible transfer to humans.
authors.affiliation: S.A.F.U. Department, Regina Elena Cancer Institute, Rome, Italy. info@enricospugnini.net
authors.forename: Enrico P
authors.initials: EP
authors.lastname: Spugnini
authors.forename: Gennaro
authors.initials: G
authors.lastname: Citro
authors.forename: Alfonso
authors.initials: A
authors.lastname: Baldi
mesh_terms: D000818:Animals; D017024:Chemotherapy, Adjuvant / Q000379:methods; D004195:Disease Models, Animal; D053672:Electrochemotherapy / Q000379:methods / Q000662:veterinary*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000662:veterinary*; D018714:Radiotherapy, Adjuvant / Q000379:methods
references.citation: Biochem Biophys Res Commun. 1993 Jul 15;194(1):333-7
references.pmid: 7687434
references.citation: Methods Enzymol. 1990;184:641-53
references.pmid: 2167431
references.citation: J Exp Clin Cancer Res. 2007 Dec;26(4):483-7
references.pmid: 18365542
references.citation: Anticancer Res. 2001 Jul-Aug;21(4A):2483-8
references.pmid: 11724311
references.citation: In Vivo. 2008 Jan-Feb;22(1):47-9
references.pmid: 18396781
references.citation: Vet Rec. 2006 Oct 28;159(18):598-600
references.pmid: 17071674
references.citation: J Exp Clin Cancer Res. 2008 Nov 12;27:67
references.pmid: 19014470
references.citation: Technol Cancer Res Treat. 2002 Oct;1(5):393-9
references.pmid: 12625765
references.citation: Surg Gynecol Obstet. 1993 Feb;176(2):124-34
references.pmid: 8421799
references.citation: Lancet. 2002 Jun 29;359(9325):2235-41
references.pmid: 12103287
references.citation: J Surg Oncol. 1993 Apr;52(4):223-30
references.pmid: 8468983
references.citation: Planta. 1981 Jan;151(1):26-32
references.pmid: 24301666
references.citation: IEEE Eng Med Biol Mag. 1999 Jan-Feb;18(1):62-6
references.pmid: 9934602
references.citation: Cancer Res. 1993 Nov 15;53(22):5462-9
references.pmid: 7693342
references.citation: In Vivo. 2007 Sep-Oct;21(5):819-22
references.pmid: 18019417
references.citation: J Exp Clin Cancer Res. 2005 Jun;24(2):245-54
references.pmid: 16110758
references.citation: Biophys Chem. 1984 May;19(3):211-25
references.pmid: 6722274
references.citation: Expert Rev Anticancer Ther. 2009 Feb;9(2):199-210
references.pmid: 19192958
references.citation: Br J Cancer. 1997;76(12):1617-22
references.pmid: 9413951
references.citation: In Vivo. 2008 Jan-Feb;22(1):51-3
references.pmid: 18396782
references.citation: Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1476-80
references.pmid: 19231097
references.citation: Cancer Chemother Pharmacol. 2007 Feb;59(3):375-81
references.pmid: 16807731
references.citation: Gene Ther. 2002 Oct;9(19):1286-90
references.pmid: 12224011
references.citation: Methods Mol Biol. 2008;433:115-25
references.pmid: 18679620
references.citation: Melanoma Res. 2006 Feb;16(1):23-7
references.pmid: 16432452
references.citation: J Exp Clin Cancer Res. 2007 Sep;26(3):343-6
references.pmid: 17987793
references.citation: Eur J Surg Oncol. 2009 Jun;35(6):568-72
references.pmid: 19013049
references.citation: J Transl Med. 2007 Oct 02;5:48
references.pmid: 17910745
references.citation: Breast Cancer Res Treat. 2009 Sep;117(2):333-8
references.pmid: 19152026
references.citation: Br J Cancer. 2008 Jan 29;98(2):388-98
references.pmid: 18182988
references.citation: Microsc Res Tech. 2007 Dec;70(12):1041-50
references.pmid: 17722056
references.citation: Cancer. 2002 Feb 1;94(3):786-92
references.pmid: 11857314
references.citation: Anticancer Res. 2006 Nov-Dec;26(6B):4585-9
references.pmid: 17201181
references.citation: Ther Clin Risk Manag. 2008 Apr;4(2):541-8
references.pmid: 18728828
references.citation: Cancer Treat Rev. 2005 Nov;31(7):555-70
references.pmid: 16168567
references.citation: J Exp Clin Cancer Res. 2003 Dec;22(4):571-80
references.pmid: 15053299
references.citation: Int J Hyperthermia. 1994 May-Jun;10(3):429-32
references.pmid: 7930810
references.citation: Vet J. 2009 Jan;179(1):117-20
references.pmid: 17904882
references.citation: Vet J. 2008 Nov;178(2):291-3
references.pmid: 17910926
references.citation: In Vivo. 2008 Nov-Dec;22(6):751-3
references.pmid: 19181001
references.citation: In Vivo. 2007 Sep-Oct;21(5):897-9
references.pmid: 18019432
references.citation: BMC Cancer. 2005 Sep 16;5:115
references.pmid: 16168056